Processing
About us
For more than 35 years, we've been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available.
Through our founder's dedication to innovation, the highest standards of quality, and deep genomics expertise, IDT has evolved from a leading oligo manufacturer to a genomics solutions provider supporting key areas such as next generation sequencing, CRISPR, synthetic biology, and PCR, equipping researchers with the right tools when they needed them. With these core efforts, IDT teams have been behind the scenes helping to drive science forward with increased quality, volume, efficiencies, and unmatched customer service.
Today, technology is evolving faster than ever before. Scientists leading the transition from basic to translational research face new challenges with securing the custom solutions necessary to advance their research out of the lab and into the clinic. These emerging barriers have collectively slowed down critical discoveries with potentially profound impacts on human and ecological health.
To help overcome these obstacles and push the boundaries of technology, we've expanded production facilities and capabilities to include GMP* and cGMP manufacturing grades. These additions provide customers with a genomics solutions partner capable of supporting the entire research journey. Combined with a renewed collaborative agility, members of our organization and strategic partners are positioned to contribute to the greatest genomic breakthroughs of our time—guiding more effective vaccines, addressing world hunger and climate change, and driving new diagnostics and therapeutics for complex diseases.
As we look to the future, our mission—accelerating the pace of genomics—honors our legacy and represents our commitment to the pursuit of new ideas that will help us realize our shared vision of enabling researchers to rapidly move from the lab to life-changing advances.
IDT by the numbers
90,000+
nucleic acids produced daily
100+
countries where researchers use our products
130,000+
researchers served
2,000+
employees worldwide
“
I’m excited by IDT’s mission, its people, and the profound impact on humanity that our company is helping to enable. Our team is on a mission to accelerate the pace of genomics; with a vision to enable researchers to rapidly move from the lab to life-changing advances. What’s truly inspiring for me is hearing from fellow colleagues about how their personal lives have been personally impacted by the scientific discoveries IDT has enabled; and the life-enhancing therapies our research customers are working on. It’s bigger than us and it’s exhilarating to get to be a part of the story. ”
Demaris Mills
President, IDT
President, IDT
IDT is proud to be part of Danaher. Danaher’s science and technology leadership puts IDT’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers.
Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
To stay up to date on IDT news follow us on Twitter, LinkedIn, Facebook, YouTube, and Instagram or sign up to become an IDT Insider.
*GMP refers to products manufactured under ISO 13485: 2016 QMS. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations for their legal marketing.